Our Research Digests

Welcome to the 101st edition of the Research Digest. This month’s edition features articles that explore exercise pathophysiology through invasive cardiopulmonary exercise testing, the role of orthostatic hemodynamic changes in cognitive impairment in Long COVID and ME/CFS, and clinical guidance for the diagnosis and management of ME/CFS. You can also join our community and choose to

Welcome to the 100th edition of Emerge Australia’s Research Digest! To commemorate the milestone of our 100th issue, we’re shining a light on Emerge Australia’s own contribution to ME/CFS (and now Long COVID) research, with the launch of AusME, the new Australian ME/CFS and Long COVID Registry and Biobank. This months Contributor and Digest Editor:

In this 99th edition of the Research Digest, we highlight the discovery of WASF3, a key protein linked to exercise intolerance in ME/CFS. We also explore the use of health survey tools to better convey the burden of ME/CFS in Australia. Additionally, we delve into the analysis of plasma samples, identifying promising metabolites for diagnosing

Welcome to the 98th edition of the Research Digest. This edition features articles that contribute to our understanding of ME/CFS and Long COVID. Alongside a Swiss report detailing the experiences of individuals with ME/CFS, the digest presents research on the enduring cognitive effects of COVID-19 and a study demonstrating the advantages of adhering to pacing

Welcome to the 97th edition of the Research Digest. July’s edition features ME/CFS studies that assess the potential diagnostic markers for ME/CFS and an article suggesting the immune and metabolic responses to intestinal cell damage are suppressed, in those living with ME/CFS. July’s edition also highlights Emerge Australia’s CEO Anne Wilson, and her focus on empowering change, for invisible illnesses.

Welcome to the 96th edition of the Research Digest. This month’s edition presents study outcomes demonstrating the presence of POTS in ME/CFS and further evidence that implicates the dysregulation of cytokine signalling in ME/CFS. This month’s Research Digest also highlights Emerge Australia’s efforts alongside members of the ME/CFS community and key stakeholders, to launch the Parliamentary Friends Group for ME/CFS, a meeting that took place at Parliament House on June 13th, 2023.

Welcome to the 95th edition of the Research Digest. This edition features a study looking at transcriptomic changes in those with ME/CFS following an exercise challenge and examines ME/CFS symptom differences in Black and White individuals. This edition also highlights the impact of Long COVID in Australia and the Conversation hour discusses Long COVID, in the context of how it’s changing the way we respond to ME/CFS.

Welcome to the 94th edition of the Research Digest. This month’s edition summarises research studies investigating the impact of exercise on post-exertional malaise, offering invaluable insights into exercise pathophysiology for both ME/CFS and Long COVID. This month’s edition also highlights the long-awaited report from the parliamentary inquiry into Long COVID, which includes a recommendation for more research and patient support for those living with ME/CFS.

Welcome to the 93rd edition of the Research Digest. This month’s edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID and finally, a local study sheds light on brain structure changes that are common to Long COVID and ME/CFS.

Welcome to the 92nd edition of the Research Digest. This month recapitulates research studies that extend our understanding of ME/CFS and Long COVID. The effect of exercise on the content of extracellular vesicles is investigated for ME/CFS and for Long COVID symptoms. This edition also highlights comments made by Professor Brendan Crabb, CEO of the Burnet Institute encouraging the government to ‘change the narrative’ to prevent the infection of COVID-19 and limit the impact of Long COVID.